Previous studies have shown that ERα can interact with the C-terminal DNA binding domain of Sp1 [59] and the binding of ERα/Sp1 complex to Sp1 sites located within the promoters of certain genes induces transcriptional changes in BC cells upon estrogen treatment [60]. The gene discussed is SP1; the disease is breast cancer.